InvestorsHub Logo
Followers 120
Posts 20756
Boards Moderated 0
Alias Born 06/13/2011

Re: eboomer2611 post# 197272

Monday, 06/17/2019 8:13:28 PM

Monday, June 17, 2019 8:13:28 PM

Post# of 426487
Eb. Agree it’s a risk but IMHO Teva wouldn’t have settled if they thought they could prevail

My understandings of the patents —- and I acknowledge that others here may know more

The patent for composition of matter devoid of DHA is unbreakable. There is no prior art .

Compositions that contain DHA may challenge BUT the R-It results are based on Vascepa .... devoid of DHA .... so there’s no assurance you
will get the same RRR

That why I don’t see DS as a real threat. If RRR from R-It had only been say 10% ... then I could see DS
with some DHA being considered an option ... but not with the actual R-It numbers we saw
JMO
Kiwi
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News